Faber, K., Bullinger, L., Ragu, C., Garding, A., Mertens, D., Miller, C., . . . Fröhling, S. (2012). CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling. American Society for Clinical Investigation.
Παραπομπή Chicago StyleFaber, Katrin, et al. CDX2-driven Leukemogenesis Involves KLF4 Repression and Deregulated PPARγ Signaling. American Society for Clinical Investigation, 2012.
Παραπομπή MLAFaber, Katrin, et al. CDX2-driven Leukemogenesis Involves KLF4 Repression and Deregulated PPARγ Signaling. American Society for Clinical Investigation, 2012.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.